secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORTHWEST BIOTHERAPEUTICS INC (NWBO)
CIK:        0001072379
Form:       8-K
Filed at:   2021-11-29T23:59:59+00:00
Accession:  0001104659-21-144456
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

NWBO enters $15M loan with Streeterville; conversion right tied to Phase III data
--------------------------------------------------------------------------------

- Net proceeds of $15M from Streeterville Capital, LLC; 22-month maturity, 8% interest, 10% OID.
- No payments first 8 months, then 14 equal monthly principal installments at 110% pro rata plus interest.
- Lender gets springing right upon top-line data from DCVax-L Phase III to convert balance into shares at 12% discount to next private placement.
- Funds will be used for ongoing business operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1072379/000110465921144456/0001104659-21-144456-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1072379/000110465921144456/tm2134065d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-21-144456

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer